Medindia
Medindia LOGIN REGISTER
Advertisement

Telaprevir May Be Viewed More Positively by Clinicians Than Boceprevir for Hepatitis C Virus Treatment Following Their Launches In 2011

Tuesday, January 19, 2010 General News
Advertisement
Uptake of Telaprevir and Boceprevir Will be Key Drivers of Substantial Overall Market Growth Through 2013, According to New Findings from Decision Resources

For more information, contact:

Decision Resources

Decision Resources, Inc.

Christopher Comfort

Elizabeth Marshall

781-296-2597

781-296-2563

[email protected]

[email protected]

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close